These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 401691)

  • 1. Long-lasting effect of oral molsydomine on exercise performance: a new antianginal agent.
    Takeshita A; Nakamura M; Tajimi T; Matsuguchi H; Kuroiwa A
    Circulation; 1977 Feb; 55(2):401-7. PubMed ID: 401691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and hemodynamic effects of the new dilator drug molsidomine.
    Malcolm AD
    Am Heart J; 1985 Mar; 109(3 Pt 2):674-7. PubMed ID: 3883734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased exercise tolerance after oral diltiazem, a calcium antagonist, in angina pectoris.
    Koiwaya Y; Nakamura M; Mitsutake A; Tanaka S; Takeshita A
    Am Heart J; 1981 Feb; 101(2):143-9. PubMed ID: 6781321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molsidomine in the treatment of patients with angina pectoris.
    Majid PA; DeFeyter PJ; Van der Wall EE; Wardeh R; Roos JP
    N Engl J Med; 1980 Jan; 302(1):1-6. PubMed ID: 6985697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Duration of the antianginal effect of oral molsidomine in exertion angina. Double-blind, crossed and randomized study].
    Bordes P; Gimeno JV; Olagüe J; Ferrer J; Hernández M; Algarra F
    Rev Esp Cardiol; 1986; 39(2):138-42. PubMed ID: 3523649
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ergometric study of a new vasodilator agent in angina: molsidomine. Value of combination with beta-blockaders].
    Witchitz S; Kolsky H; Moisson P; Valette H
    Arch Mal Coeur Vaiss; 1981 Apr; 74(4):463-71. PubMed ID: 6112971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term hemodynamic, anti-ischemic, and antianginal effects of pirsidomine, a new sydnonimine.
    Stengele E; Ruf G; Jähnchen E; Trenk D; Löffler K; Schulz W; Roskamm H
    Am J Cardiol; 1996 May; 77(11):937-41. PubMed ID: 8644642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased exercise tolerance after nitroglycerin oral spray: a new and effective therapeutic modality in angina pectoris.
    Kimchi A; Lee G; Amsterdam E; Fujii K; Krieg P; Mason DT
    Circulation; 1983 Jan; 67(1):124-7. PubMed ID: 6401172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of molsidomine on exercise-ECG'S In coronary insufficiency (author's transl)].
    Grewe N; Stauch M
    Dtsch Med Wochenschr; 1977 Dec; 102(48):1758-63. PubMed ID: 923459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antianginal effect of molsidomine in prolonged oral therapy. A double blind, crossover, randomized study.
    Baudry C
    Acta Cardiol; 1982; 37(1):23-30. PubMed ID: 7044013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molsidomine--an effective antianginal drug. Results of an acute randomized stress-testing study.
    Mindlin de Aptecar FR; Vazquez A; Aptecar M
    Cardiology; 1985; 72(4):185-92. PubMed ID: 3902224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term molsidomine treatment versus isosorbide dinitrate and placebo on exercise tolerance in stable angina.
    Romano M; de Caprio L; Meccariello P; Cuomo S; Baldini F; D'Ascia C; Steinberg G; Chiariello M
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):246-9. PubMed ID: 6430811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of molsidomine at rest and during submaximal and maximal exercise in patients with coronary artery disease limited by exertional angina pectoris.
    Detry JM; Melin J; Brasseur LA; Cosyns J; Rousseau MF
    Am J Cardiol; 1981 Jan; 47(1):109-15. PubMed ID: 6893896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the chronic antianginal effect of molsidomine.
    Dalla-Volta S; Scorzelli L; Razzolini R
    Am Heart J; 1985 Mar; 109(3 Pt 2):682-4. PubMed ID: 3883736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of molsidomine on exercise tolerance in patients with exertional angina pectoris.
    Kinoshita M; Sawamura M; Motomura M; Takayama Y; Kawaguchi Y; Kawakita S
    Jpn Circ J; 1983 Dec; 47(12):1398-405. PubMed ID: 6689183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molsidomine: evaluation of a single dose using the exercise test].
    Ruano J; Zueco J; Colman T; López C; Pajarón A
    Rev Esp Cardiol; 1985; 38(2):93-7. PubMed ID: 3890039
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemodynamic effects of molsidomine in patients with acute myocardial infarction.
    Reifart N; Neidl K; Kaltenbach M; Bussmann WD
    Am Heart J; 1985 Mar; 109(3 Pt 2):708-12. PubMed ID: 3919550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance.
    Thadani U; Hamilton SF; Olson E; Anderson J; Voyles W; Prasad R; Teague SM
    Ann Intern Med; 1986 Oct; 105(4):485-92. PubMed ID: 3092711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and hemodynamic effect of molsidomine in patients with unstable angina pectoris].
    Beloev I; Tomov I; Elenkova A; Terzieva L
    Vutr Boles; 1982; 21(3):62-9. PubMed ID: 6810552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained hemodynamic and antianginal effect of high dose oral isosorbide dinitrate.
    Danahy DT; Burwell DT; Aronow WS; Prakash R
    Circulation; 1977 Feb; 55(2):381-7. PubMed ID: 401690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.